51715 injects bulking material into urethral or bladder-neck tissue to improve outlet closure. 52287 injects the bladder for chemodenervation, rather than treating urethral sphincter weakness.
On this page
CMS RVU26D · Effective 2026-10-01
51715 Urethral bulking Medicare reimbursement rates in Virginia
Endoscopic injection of bulking material into urethral or bladder-neck tissue to improve closure in patients with stress urinary incontinence. Compare 51715 office and facility rates across CMS payment localities in Virginia.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 51715 in Virginia?
Virginia has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
$337.64–$391.79
2 of 2 localities have a supported rate.
Facility setting
$170.52–$191.52
2 of 2 localities have a supported rate.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Urology procedure
About 51715: Endoscopic urethral bulking injection
Endoscopic injection of bulking material into urethral or bladder-neck tissue to improve closure in patients with stress urinary incontinence.
A urologist or urogynecologist uses a cystoscope to place bulking material beneath the lining of the urethra and/or bladder neck. The added volume helps the outlet close more effectively. The procedure is used for stress urinary incontinence associated with inadequate urethral sphincter closure, including cases in which a patient and clinician select an injection approach rather than a sling operation. It is commonly performed in an ambulatory or office-based setting, depending on the technique and clinical circumstances.
Report one unit for the endoscopic injection service, not a separate unit for each deposit of material. The record should identify the incontinence indication, injection site, material, and endoscopic procedure performed. Cystoscopic access and visualization are part of the injection service; do not separately report routine diagnostic cystoscopy for that same work. The code has a 0-day global period, so same-day preoperative and postoperative care is included. When multiple procedures are performed in one session, the highest-valued procedure is paid in full and the others are reduced to 50%. Bilateral adjustment is inappropriate. Assistant-at-surgery payment requires documented medical necessity; co-surgeons and team surgery are not permitted.
CMS billing rules for 51715
- Global period
- Minor procedure with a 0-day global period: same-day preoperative and postoperative care is included.
- Multiple procedures
- Standard multiple procedure reduction: the highest-valued procedure is paid in full and others at 50% when performed in the same session.
- Bilateral procedures
- Bilateral adjustment does not apply; the descriptor or anatomy makes modifier 50 inappropriate.
- Assistant at surgery
- Assistant at surgery is paid only with documentation of medical necessity.
- Co-surgeons
- Co-surgeons not permitted.
- Team surgery
- Team surgery not permitted.
Where the value comes from
- Work RVU3.64 · 35%
- Practice expense (office) RVU6.20 · 60%
- Malpractice RVU0.53 · 5%
16.9K
Medicare services in 2024 · #1210 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
51715 compared with similar codes
Office rates for Virginia, from the same CMS release.
52327 treats vesicoureteral reflux by injection at the ureteral orifice. 51715 targets urethral or bladder-neck tissue for stress urinary incontinence.
57288 is a sling operation for stress urinary incontinence. Use 51715 for endoscopic injection of bulking material, not sling placement.
Compare 51715 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Dc + Md/Va Suburbs →
Office / nonfacility
$391.79
Facility
$191.52
Virginia →
Office / nonfacility
$337.64
Facility
$170.52
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
51715 billing questions
How is 51715 different from a bladder Botox injection?
51715 places bulking material in urethral or bladder-neck tissue to improve outlet closure. CPT 52287 describes bladder chemodenervation, commonly used for overactive bladder.
Can diagnostic cystoscopy be billed separately on the same date?
Routine cystoscopic access and visualization are integral to the endoscopic injection. Do not separately report diagnostic cystoscopy for that same work.
Should the code be billed once for each injection deposit?
No. Report one unit for the procedure, rather than counting individual deposits of bulking material as separate units.
Is modifier 50 appropriate when treatment involves both sides?
No. CMS identifies bilateral adjustment as inappropriate for this code. Report the endoscopic injection service without a bilateral modifier.
What documentation supports reporting 51715?
Document the stress-incontinence indication, the urethral or bladder-neck injection site, the bulking material used, and the endoscopic service performed.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
